Figure_1.tif (476.22 kB)
Immunogenicity of two doses of pH1N1 vaccine.
figure
posted on 2013-02-20, 20:53 authored by Darius Soonawala, Guus F. Rimmelzwaan, Luc B. S. Gelinck, Leo G. Visser, Frank P. KroonMonovalent MF59-adjuvanted pandemic influenza vaccine (A/California/7/2009) administered to a group of 57 HIV-infected patients (HIV) and 44 healthy controls (HC). The vaccine was administered at day 0 (baseline) and at day 21. Age adjusted geometric mean titers with 95% confidence intervals at baseline, day 7, day 21 and day 56 (Panel A). Reverse cumulative distribution curves on hemagglutination inhibition assay at baseline and at day 21 (Panel B).
